Market valued at $1.45B in 2024 grows at 10.4% CAGR driven by biocompatible hemostatic solutions in surgical and trauma ...
Market set for 11.6% CAGR driven by sustainability push and circular economy adoption in medical device manufacturing - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results